In a special issue of the Cell Press journal Neuron, experts debated the challenges associated with “translational neuroscience,” and the efforts that should be made to commercialize advances made in the laboratory so that patients can benefit from them.

Despite the major advances that science is making in understanding how the human brain works, several neurodegenerative disorders and psychiatric conditions are on the rise and are becoming more frequent, outpacing diagnostic and treatment approaches.

Dr. Katja Brose, Neuron Editor, explained: “A variety of global impact studies have identified brain disorders as a leading contributor to disabilities and morbidity worldwide with a critical economic, public health, and societal impact (…) There is resounding agreement that we need new approaches and strategies, and there are active efforts, discussion, and experimentation aimed at making the process of therapeutic development more efficient and effective.”

Links

Time Magazine Article
Press Release (Eurekalert)

ноември 5, 2014